UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

3D-neuronavigation in vivo through a patient's brain during a spontaneous migraine headache

Journal of visualized experiments, 2014-06 (88)

2014

Volltextzugriff (PDF)

Belief or Need? Accounting for individual variations in the neurochemistry of the placebo effect

Brain, behavior, and immunity, 2006, Vol.20 (1), p.15-26

2006

Volltextzugriff (PDF)

Brief Report: Excitatory and Inhibitory Brain Metabolites as Targets of Motor Cortex Transcranial Direct Current Stimulation Therapy and Predictors of Its Efficacy in Fibromyalgia

Arthritis & Rheumatology, 2015-02, Vol.67 (2), p.576-581

2015

Volltextzugriff (PDF)

Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report

PloS one, 2014-07, Vol.9 (7), p.e102350

2014

Volltextzugriff (PDF)

Chapter 4 - Molecular Mechanisms of Placebo Responses in Humans

Placebo and Pain, 2014, p.25-36

2014

Volltextzugriff (PDF)

COMT$val^{158}met$Genotype Affects$\mu -Opioid$Neurotransmitter Responses to a Pain Stressor

Science (American Association for the Advancement of Science), 2003-02, Vol.299 (5610), p.1240-1243

2003

Volltextzugriff (PDF)

COMT val158met genotype affects μ-opioid neurotransmitter responses to a pain stressor

Science (American Association for the Advancement of Science), 2003-02, Vol.299 (5610), p.1240-1243

2003

Volltextzugriff (PDF)

Decreased central mu-opioid receptor availability in fibromyalgia

The Journal of neuroscience, 2007-09, Vol.27 (37), p.10000-10006

2007

Volltextzugriff (PDF)

Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans

Neuropsychopharmacology (New York, N.Y.), 2015-02, Vol.40 (3), p.554-565

2015

Volltextzugriff (PDF)

Effect of High-Definition Transcranial Direct Current Stimulation on Headache Severity and Central µ-Opioid Receptor Availability in Episodic Migraine

Journal of pain research, 2023-01, Vol.16, p.2509-2523

2023

Volltextzugriff (PDF)

Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission

Molecular psychiatry, 2022-02, Vol.27 (2), p.831-839

2022

Volltextzugriff (PDF)

Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures

Neuropsychopharmacology (New York, N.Y.), 2015-03, Vol.40 (4), p.957-965

2015

Volltextzugriff (PDF)

Expectancy Modulation of Opioid Neurotransmission

International review of neurobiology, 2018, Vol.138, p.17-37

2018

Volltextzugriff (PDF)

Exploring HD-tDCS Effect on μ-opioid Receptor and Pain Sensitivity in Temporomandibular Disorder: A Pilot Randomized Clinical Trial Study

The journal of pain, 2024-04, Vol.25 (4), p.1070-1081

2024

Volltextzugriff (PDF)

Impaired frontostriatal functional connectivity among chronic opioid using pain patients is associated with dysregulated affect

Addiction biology, 2020-03, Vol.25 (2), p.e12743-n/a

2020

Volltextzugriff (PDF)

Individual Differences in Reward Responding Explain Placebo-Induced Expectations and Effects

Neuron (Cambridge, Mass.), 2007-07, Vol.55 (2), p.325-336

2007

Volltextzugriff (PDF)

Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors

Progress in neuro-psychopharmacology & biological psychiatry, 2005-12, Vol.29 (8), p.1264-1280

2005

Volltextzugriff (PDF)

Migraine and the Mu-Opioidergic System—Can We Directly Modulate it? Evidence from Neuroimaging Studies

Current pain and headache reports, 2014-07, Vol.18 (7), p.429-429, Article 429

2014

Volltextzugriff (PDF)

Molecular Mechanisms of Placebo Responses in Humans

Placebo and Pain, 2013, Vol.1, p.25-36

2013

Volltextzugriff (PDF)

μ‐Opioid activation in the midbrain during migraine allodynia – brief report II

Annals of clinical and translational neurology, 2014-06, Vol.1 (6), p.445-450

2014

Volltextzugriff (PDF)

mu-opioid receptor-mediated antinociceptive responses differ in men and women

The Journal of neuroscience, 2002-06, Vol.22 (12), p.5100-5107

2002

Volltextzugriff (PDF)

Neurobiological Mechanisms of Placebo Responses

Annals of the New York Academy of Sciences, 2009-03, Vol.1156 (1), p.198-210

2009

Volltextzugriff (PDF)

Neurobiological mechanisms of the placebo effect

The Journal of neuroscience, 2005-11, Vol.25 (45), p.10390-10402

2005

Volltextzugriff (PDF)

Personality Trait Predictors of Placebo Analgesia and Neurobiological Correlates

Neuropsychopharmacology (New York, N.Y.), 2013-03, Vol.38 (4), p.639-646

2013

Volltextzugriff (PDF)

Placebo effects mediated by endogenous opioid activity on mu-opioid receptors

The Journal of neuroscience, 2005-08, Vol.25 (34), p.7754-7762

2005

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

ThemaPain

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(35)
Buchkapitel
(2)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

3D-neuronavigation in vivo through a patient's brain during a spontaneous migraine headache

Belief or Need? Accounting for individual variations in the neurochemistry of the placebo effect

Brief Report: Excitatory and Inhibitory Brain Metabolites as Targets of Motor Cortex Transcranial Direct Current Stimulation Therapy and Predictors of Its Efficacy in Fibromyalgia

Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report

Chapter 4 - Molecular Mechanisms of Placebo Responses in Humans

COMT$val^{158}met$Genotype Affects$\mu -Opioid$Neurotransmitter Responses to a Pain Stressor

COMT val158met genotype affects μ-opioid neurotransmitter responses to a pain stressor

Decreased central mu-opioid receptor availability in fibromyalgia

Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans

Effect of High-Definition Transcranial Direct Current Stimulation on Headache Severity and Central µ-Opioid Receptor Availability in Episodic Migraine

Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission

Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures

Expectancy Modulation of Opioid Neurotransmission

Exploring HD-tDCS Effect on μ-opioid Receptor and Pain Sensitivity in Temporomandibular Disorder: A Pilot Randomized Clinical Trial Study

Impaired frontostriatal functional connectivity among chronic opioid using pain patients is associated with dysregulated affect

Individual Differences in Reward Responding Explain Placebo-Induced Expectations and Effects

Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors

Migraine and the Mu-Opioidergic System—Can We Directly Modulate it? Evidence from Neuroimaging Studies

Molecular Mechanisms of Placebo Responses in Humans

μ‐Opioid activation in the midbrain during migraine allodynia – brief report II

mu-opioid receptor-mediated antinociceptive responses differ in men and women

Neurobiological Mechanisms of Placebo Responses

Neurobiological mechanisms of the placebo effect

Personality Trait Predictors of Placebo Analgesia and Neurobiological Correlates

Placebo effects mediated by endogenous opioid activity on mu-opioid receptors

Aktive Filter

Suchergebnisse filtern